OPTICROM Allergy Eye drops, solution Ref.[27787] Active ingredients: Cromoglicic acid

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Aspire Pharma Limited, Unit 4, Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, United Kingdom

4.1. Therapeutic indications

For the relief and treatment of seasonal and perennial allergic conjunctivitis.

4.2. Posology and method of administration

Topical ophthalmic administration

One or two drops in each eye four times a day or as indicated by the doctor.

Older people

There is no evidence to suggest that dosage alteration is required for elderly patients.

4.9. Overdose

No action other than medical observation should be necessary.

6.3. Shelf life

30 months.

After first opening the bottle: 4 weeks

Discard any remaining solution four weeks after first opening.

6.4. Special precautions for storage

Before first opening the bottle: This medicinal product does not require any special storage conditions

After first opening the bottle: Do not store above 25°C.

6.5. Nature and contents of container

Low density polyethylene (LDPE) bottle with a low density polyethylene/ high density polyethylene cap with a tamper proof cap containing either 5ml or 10ml of solution.

Pack sizes: 1x5ml and 1x10ml

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

No special requirements.

Before using the medication for the first time, be sure that the tamper-proof seal on the bottle neck is unbroken. A gap between the bottle and the cap is normal for an unopened bottle.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.